Skip to main content
. 2020 Oct 21;9(10):2331. doi: 10.3390/cells9102331

Table 1.

Effects of GHRH-R antagonists in lung inflammation and cancer models.

GHRH-R Antagonists Model System Pathways Implicated in Effects Potential Effects Reference
MZ-5-156 Lung cancer AMPK ↑
Akt/mTOR ↓
GSK3β ↓
Anti-proliferative [15]
MIA-602 Lung endothelial cells ERK ↓
JAK2/STAT3 ↓
p53 ↑
AMPK ↑
anti-inflammatory [16]
MIA-602 Mouse lung and fibroblasts ERK ↑
Akt ↓
anti-inflammatory, anti-fibrotic, pro-apoptotic [17]